Physician profile
Robert Duerr
NPI 1447508189
$36,441.10
in general payments reported to CMS, 2019-2025
22 companies · $2,552 in 2025
The $2,552 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,433 · 2020: $1,149 · 2021: $2,321 · 2022: $8,071 · 2023: $7,649 · 2024: $11K · 2025: $2,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,904 · Food and Beverage: $5,688 · Consulting Fee: $5,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Honoraria: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,903.65 |
| Food and Beverage | $5,688.12 |
| Consulting Fee | $5,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Honoraria | $1,375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $9,674.87 | 2022-2025 | |
| Arthrex, INC. | $9,558.04 | 2019-2025 | Arthrex, Knee & Hip Implants Meniscal Repair Fiberstitch, Knee & Hip Implants Collateral Ligament |
| Vericel Corporation | $7,258.44 | 2022-2024 | Maci |
| Cdc Medical LLC | $5,670.03 | 2019-2022 | |
| Stryker Corporation | $1,309.71 | 2021-2025 | Mako, Blueprint Patient Specific Instrumentation, Iconix |
| Impactortho, INC. | $1,212.28 | 2022 | |
| Smith+Nephew, INC. | $470.31 | 2019-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Spatial Frame, Stravix Pl |
| Nuo Therapeutics | $400.71 | 2022-2024 | |
| Bodycad USA Corp | $283.96 | 2021 | |
| Linvatec Corporation | $135.78 | 2022 | |
| Mid-Atlantic Surgical Systems, LLC | $127.02 | 2025 | |
| Ossur Americas, INC. | $61.13 | 2024-2025 | Unloader One X, Miami J |
| Kerecis Limited | $56.87 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Ferring Pharmaceuticals INC. | $55.86 | 2023-2025 | Euflexxa |
| Ethicon US, LLC | $32.14 | 2024 | Stratafix, Vistaseal, Monocryl |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $26.94 | 2025 | Triclip |
| Sanara Medtech INC. | $23.59 | 2023 | Celleraterx |
| Depuy Synthes Sales INC. | $22.74 | 2025 | Inhance |
| Kci USA, INC. | $16.73 | 2023 | Prevena |
| Kowa Pharmaceuticals America, INC. | $15.60 | 2023 | Seglentis |
| Treace Medical Concepts, INC. | $14.50 | 2023 | |
| Integra Lifesciences Corporation | $13.85 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Duerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.